Forvard P/S multiplikatori: SBC Medical Group Holdings Inc. (SBC)

SBC Medical Group Holdings Inc - SBC emitenti grafik logotipi

Minimal invaziv yoshartirishga bo'lgan talabning ortishi va franchayzingning rivojlanishi SBC Medical Group Holdings Inc (SBC) o'sishini ta'minlamoqda, bu esa prognoz qilingan P/S tendentsiyasini tasdiqlaydi. 3.20 darajasi ushbu metrikaning joriy qiymatini ifodalaydi. Biznesning daromadliligi o'rtacha chek va shifokorlarning saqlanib qolishiga bog'liq, operatsion samaradorlik esa tashqi IT xizmatlari va logistikautsorsing orqali ta'minlanadi.

SBC Medical Group - SBC Kapitalizatsiyaning prognoz qilingan daromadga nisbati (davr: 16.11.2024 - 18.11.2026)

SBC Medical Group Holdings Inc (SBC) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- bozor narxi va tahlilchilarning maqsadli narxlari:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning fundamental tahlili:SBC (SBC Medical Group Holdings)
SBC Medical Group Inc tovar namunasi

Oldingi P/S koeffitsiyenti kompaniyaning bozor qiymatini kutilayotgan daromadlariga nisbatan o'lchaydi, bu esa kapital xarajatlarining oshishi sharoitida spekulyativ o'sishni fundamental kuchdan ajratish imkonini beradi. Kutilayotgan P/S metriki orqali ko'rsatilgan 3.20 ning joriy qiymati, SBC Medical Group Holdings Inc (SBC) kompaniyasining Yaponiyaning estetik tibbiyoti sohasidagi ustunligi uchun premiumni aks ettiradi, bu yerda tor ixtisoslashgan nisha kapital barqarorligini tasdiqlash uchun daromadlar prognozi aniqligini qat'iy nazorat qilishni talab etadi.

SBC Medical Group Holdings Inc kimlar bilan raqobatlashadi

Forvard P/S multiplikatori HCA (HCA Healthcare, Inc.)|Narxning kutilayotgan daromadga nisbati THC (Tenet Healthcare)|FMS - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati solventum.com|EHC: Forvard P/S multiplikatori|UHS - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|DVA (DaVita Corp) - Forvard P/S multiplikatori|RDNT: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori OPCH|SGRY (surgerypartners.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori PINC (Premier Inc)|National Vision - Narxning prognoz qilingan daromadga nisbati|PGNY - Narxning prognoz qilingan daromadga nisbati|ARDT - Forvard P/S multiplikatori|SEM: Forvard P/S multiplikatori|astranahealth.com (ASTH) - Forvard P/S multiplikatori|MD (mednax.com) - Forvard P/S multiplikatori|Forvard P/S multiplikatori usph.com|Forvard P/S multiplikatori PNTG|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Organogenesis Holdings|Forvard P/S multiplikatori NUTX (nutexhealth.com)|Auna SA (AUNA) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|EOLS - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx CYH (Community Health Systems Inc)|SKIN (beautyhealth.com) - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati MDWD|Narxning prognoz qilingan daromadga nisbati biote Corp.|Bozor kapitallashuvining kelajakdagi daromadga nisbati thejoint.com JYNT|Forvard P/S multiplikatori DCGO|Forvard narx/daromad multiplikatori P3 Health PIII|Forvard P/S multiplikatori GANX (Gain Therapeutics Inc.)|Forvard P/S multiplikatori EUDA Health Holdings Limited EUDA|baselmedical.com - Forvard P/S multiplikatori|CLGN: Narxning prognoz qilingan daromadga nisbati|Cuprina Holdings (Cayman) Ltd. (CUPR) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Concord Medical|AMS (American Shared Hospital Services Inc) - Forvard P/S multiplikatori|MEDIROM Corp (MRM) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori ALBT|Kapitalizatsiyaning kutilayotgan sotuvga nisbati DIH Holding|Forvard P/S multiplikatori XAGE (carmellcosmetics.com)|NIVF: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|ATIP: Forvard narx/daromad multiplikatori|CareMax Medical Group - Narxning kutilayotgan daromadga nisbati|Kindly MD (KDLY) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati MODV|Narxning prognoz qilingan daromadga nisbati Novo Integrated Sciences Corp|Bozor kapitallashuvining kelajakdagi daromadga nisbati SunLink Health Systems SSY|Narxning prognoz qilingan daromadga nisbati IMAC Corp (BACK)